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The role of astrocytes in the immune-mediated inflammatory response in the brain
is more prominent than previously thought. Astrocytes become reactive in response
to neuro-inflammatory stimuli through multiple pathways, contributing significantly to
the machinery that modifies the parenchymal environment. In particular, astrocytic
signaling induces the establishment of critical relationships with infiltrating blood
cells, such as lymphocytes, which is a fundamental process for an effective immune
response. The interaction between astrocytes and T-cells involves complex modifications
to both cell types, which undergo micro-anatomical changes and the redistribution
of their binding and secretory domains. These modifications are critical for different
immunological responses, such as for the effectiveness of the T-cell response, for the
specific infiltration of these cells and their homing in the brain parenchyma, and for
their correct apposition with antigen-presenting cells (APCs) to form immunological
synapses (ISs). In this article, we review the current knowledge of the interactions
between T-cells and astrocytes in the context of immune-mediated inflammation in the
brain, based on the micro-anatomical imaging of these appositions by high-resolution
confocal microscopy and three-dimensional rendering. The study of these dynamic
interactions using detailed technical approaches contributes to understanding the function
of astrocytes in inflammatory responses and paves the way for new therapeutic strategies.
Keywords: astrocyte, T-cell, immunological synapse, infiltration, cytokines, chemokines, glioma, immune response
INTRODUCTION
Astrocytes are sensitive to changes in the brain parenchyma
and become reactive in the presence of inflammatory stimuli,
changing both their protein expression and phenotype. These
cellular modifications are characterized by an apparent augmen-
tation of cell body size, an increased number of primary and
secondary branches, and an intensification of various signaling
cascades, such as ATP-mediated and cytokine-mediated signal-
ing, often resulting in the overexpression of certain proteins, such
as intermediate filament proteins, cytokines, and chemokines
(Buffo et al., 2010; Kang and Hebert, 2011; Molofsky et al., 2012;
Sun and Jakobs, 2012). The role of these responses is not well
established and might be multifaceted and different for each
neuro-pathological scenario and for each brain region (Zhang
and Barres, 2010; Oberheim et al., 2012). Generally, when astro-
cytes become reactive in response to injury or inflammation, glial
fibrillary acidic protein (GFAP), as well as other intermediate
filament proteins such as nestin and vimentin, become over-
expressed (Pekny and Nilsson, 2005; Buffo et al., 2008, 2010).
Although it is a widely used and reliable marker for astrocytes,
GFAP’s function remains poorly understood. Furthermore, the
existence of different isoforms of GFAP and different populations
of astrocytes adds further complexity to understanding the role
of GFAP. It is thought that GFAP may participate in many cel-
lular processes, such as motility, proliferation, autophagy, synap-
tic plasticity, neural outgrowth, myelination, injury protection,
and blood brain barrier (BBB) formation (Middeldorp and Hol,
2011). Importantly, some of these tasks are intimately related
to immune-mediated inflammation and seem to be crucial for
adequate responses in pathological conditions, particularly for
protoplasmic astrocytes, which reside in the graymatter and form
the neurovascular unit (Dirnagl, 2012).
The mechanism that induces the spatial reorganization of
astrocytes appears to be multifaceted (Buffo et al., 2010; Kang
and Hebert, 2011). One of the most important pathways that
triggers this reactivity involves cAMP, which represents a crucial
player in astrocyte cell-to-cell communication (Grimaldi et al.,
1999; Pascual et al., 2005). Injured cells release or leak ATP
into the intercellular space, thereby activating the P2 receptors
of neighboring astrocytes and initiating structural modifications.
Additionally, the release of cytokines into the extracellular space,
either by infiltrating blood cells or by neighboring glial cells,
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also contributes to astrocytic reactivity by stimulating cytokine
receptors present on the astrocyte cell surface (Buffo et al., 2010;
Hamby and Sofroniew, 2010).
Inflammatory GFAP immunoreactivity can be observed in
brain injuries and in most prominent neurodegenerative disor-
ders, such as Parkinson’s disease (Forno et al., 1992), Alzheimer’s
disease (Diedrich et al., 1987), Huntington’s disease (Galatioto,
1996), and multiple sclerosis (Darvesh et al., 2010), suggesting
the involvement of glia-mediated inflammation in the process
of degeneration. Particular attention should be given to gliomas,
which are primary brain tumors that have astrocytic character-
istics. Glioma cells originate from neural stem cells or oligoden-
drocyte progenitor cells (Sanai et al., 2005; Lindberg et al., 2009)
but can also be derived from mature astrocytes or differenti-
ated neurons that change their phenotype to a glioma cell-type
(Friedmann-Morvinski et al., 2012). However, independently of
their origin, glioma cells express high amounts of GFAP and
vimentin (Herpers et al., 1986), much like reactive astrocytes in
other inflammatory scenarios. Glioma cell morphology within
the tumor is variable; it is difficult to define a particular shape
for these cells. In addition, glioma cells are co-located with non-
neoplastic resident astrocytes, which makes it even more difficult
to distinguish between these two cell types (Figure 1). In exper-
imental models, marking inoculated glioma cells with green flu-
orescent protein (GFP) or with similar markers makes it possible
to identify glioma cells (Tatenhorst et al., 2005). In this particular
model, artificially implanted GFP+ glioma cells adopt a unipo-
lar morphology, with the major processes closely aligned with
blood vessels (BVs) and intercalated between endothelial cells and
resident GFAP+ protoplasmic astrocytes (Farin et al., 2006). This
FIGURE 1 | Morphology of human astrocytes by immunohisto-
chemistry. (A) Astrocytes in the human cortex visualized by GFAP
immunohistochemistry through DAB precipitation in the peritumoral
area of a glioma. (B) Astrocytes in human cortex visualized by
GFAP immunofluorescence in the peritumoral area of a glioma.
(C) Three-dimensional transparency of vimentin+ cells in human
glioblastoma. Cells in the tumor areas were marked using
immunohistochemistry with antibodies against vimentin (red) and
were scanned with high-resolution confocal microscopy. Some cells
maintain the typical astrocytic star shape (∗), whereas others
show the neoplastic morphology (+) that is characteristic of
astrocytomas [modified from Carrillo-de Sauvage et al. (2012)].
Scale bar: 30μm in (A) and (C); 25μm in (B).
evidence suggests that similar intercellular apposition between
resident astrocytes and glioma cells may occur in human glioma.
In addition, glioma cells are also in constant mitosis, which
entails frequent morphological changes and dramatic modifica-
tions of the intercellular space, together with the breaking of the
intercellular matrix (Ziu et al., 2006). Together, these features of
the astrocytic reactivity of glioma cells are important contribu-
tors to glia-mediated inflammation in neoplastic areas, sharing a
common response with neurodegenerative disorders.
In these brain diseases, astrocyte reactivity is a clear hallmark
of glia-mediated inflammation and is a critical contributor to
the local inflammatory environment of the brain parenchyma.
Specifically, these reactive morphological changes, together with
the anatomical location of protoplasmic astrocytes, are thought
to be important factors for the regulation of blood cell recruit-
ment (Voskuhl et al., 2009), particularly the infiltration of T
lymphocytes, which is an essential event in immune responses in
the CNS.
The frequency of T-cell entry into the brain parenchyma is
low in a healthy brain. Limited subsets of T-cells patrol the CNS
tissue, carrying out regular immuno-surveillance. Thus, a mas-
sive migration of immune cells to the CNS takes place only
during neuro-inflammation (Engelhardt and Ransohoff, 2012).
The significance of T-cell infiltration is critical in many CNS
inflammatory responses. T-cells are involved in the destruction
of myelin sheaths in multiple sclerosis and in experimental aller-
gic encephalomyelitis. Additionally, brain-infiltrating T-cells are
crucial to controlling brain infections, as occurs in viral or bacte-
rial invasion and in other cases of encephalitis. However, the func-
tion of CNS-infiltrating T-cells in other brain diseases, such as
in brain cancer or in neurodegenerative diseases, remains poorly
understood. It is thought that certain specific subpopulations
of T-cells, such as regulatory T-cells, may facilitate the progres-
sion of brain tumors (Sugihara et al., 2009); these T-cells are
putative targets for immunotherapy (Von Boehmer and Daniel,
2013). Degenerative diseases, such as Alzheimer’s disease and
Parkinson’s disease, also show infiltrating T-cells in degenerat-
ing brain regions, but the role of these infiltrating T-cells remains
unclear (Togo et al., 2002; Brochard et al., 2009).
Astrocyte reactivity, and the subsequent entry of T-cells to the
brain parenchyma, may be a fundamental aspect of the inflam-
matory response in CNS diseases. Thus, technical approaches for
imaging the inter-relationship between T-cells and reactive astro-
cytes in vivo in the neuro-inflammatory environment are crucial
to understanding the intricate phenomenon of T-cell infiltration
and its function.
HOW TO VISUALIZE ASTROCYTES IN THE TISSUE
To visualize astrocytes in tissue, the use of GFAP-specific anti-
bodies for immunohistochemistry techniques results in specific,
feasible and reliable staining. GFAP immunohistochemistry is
particularly suitable for mature fibrous astrocytes and reactive
astrocytes, although the levels of GFAP are heterogeneous in
astrocytes, and GFAP is also expressed in progenitor cells in
the adult mouse (Garcia et al., 2004). Other markers, such as
S100B, Reelin, and vimentin, have the limitation of identify-
ing other differentiated cell types, such as oligodendrocytes or
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neurons, making it difficult to distinguish astrocytes from other
mature cells (Molofsky et al., 2012). Antibodies against S100B,
a glia-specific calcium binding protein, provide robust astrocytic
detection but also label mature oligodendrocytes. The use of anti-
bodies against Reelin/Slit, an extracellular matrix protein, detects
astrocytes in the early stages of development but may also label
neurons. Antibodies against vimentin, which strongly label reac-
tive astrocytes, may also label amoeboid microglia and active
macrophages [for an extended list of astrocytic markers, see the
article by Molofsky et al. (2012)]. Because GFAP-specific anti-
bodies do not bind to other differentiated cell types, this marker
is most likely the best available option for in tissue studies. By
contrast, one of the disadvantages of GFAP immunohistochem-
ical staining in tissue is that GFAP does not identify the entire
cell body; additionally, some of the micro-anatomical character-
istics and details of astrocytes are not easy to visualize under
the microscope. Studies performed using transgenic mice with
enhanced GFP (eGFP)-expressing astrocytes (Nolte et al., 2001;
Suzuki et al., 2003) allowed the imaging of entire astrocytes in a
living brain. High-resolution imaging of eGFP-expressing astro-
cytes reveals fine processes emerging from the cell body, whereas
GFAP immune-reactivity remains limited to the perinuclear areas
and the thick processes (Suzuki et al., 2003). This result advo-
cates the use of eGFP as preferable, when possible, because eGFP
provides detailed morphological information about the entire
cell that cannot be detected with GFAP immunohistochemistry.
Another option that allows a fine and detailed analysis of the
entire astrocytic cell is the dye-filling method, which has the
advantage of inoculating specific dyes within fixed brain tissue
after extraction and fixation (Wilhelmsson et al., 2006); thus, this
technique can be used in fixed tissue from human biopsies.
Currently, the two best microscopy options for visualizing
brain cells within tissue are confocal and two-photonmicroscopy.
Both techniques are complementary and can be used to answer
different questions regarding the visualization of astrocytes. Two-
photon microscopy allows the study of live cells in vivo within
the brain (Theer et al., 2003; Helmchen and Denk, 2005). With
this approach, live cells can be visualized several hundredmicrons
deep within the tissue of living animals, and this approach has the
advantage that the interactions of living cells can be studied in
time lapse experiments (Theer et al., 2003; Helmchen and Denk,
2005). However, particularly deep brain areas, such as the basal
ganglia, thalamus, and other associated structures, are difficult, if
not impossible, to visualize unless micro-endoscopy is used (Jung
et al., 2004). However, the resolution of two-photon microscopy
is still insufficient to visualize the micro-anatomical details of
intercellular interactions; furthermore, the availability of impor-
tant fluorophores prevents the labeling of multiple structures or
molecules simultaneously in vivo. Although confocal analysis of
fixed cell culture preparations or of fixed tissue slides provides
static images, the advantage of this analysis is the ability to observe
structures at high resolution; thus, the micro-anatomical details
of intercellular interactions can be appreciated. In addition, with
multiple fluorochromes available, the use of confocal microscopy
allows the use of many markers simultaneously, permitting the
visualization of several structures with high detail in the same
frame. For these reasons, confocal microscopy in fixed tissue
may be preferable for analyzing the micro-anatomical details of
intercellular interactions at high-resolution, whereas intra-vital
two-photon microscopy is preferable for studying the dynamic
view of the cellular interactions in the brain parenchyma.
To successfully study the micro-anatomical details of intercel-
lular interactions in three-dimensional space within fixed tissue,
the immunohistochemistry protocol requires the following tech-
nical specifications: (1) thick sections of tissue for recording the
maximum amount of information; (2) specific antigen retrieval
treatment for particular epitopes; and (3) long incubations of
24–48 h with primary antibodies. These specifications allow the
antibodies to optimally penetrate to 50–60μm within the tis-
sue, obtaining uniform staining throughout the thickness of the
sections. Therefore, the confocal analysis can be performed in
depth, and the interactions between the cells can be visual-
ized and analyzed at high detail. In addition, confocal scanning
requires a large number of optical sections in order to record
high-resolution detail along the z-axis, spanning entire cells and
the surrounding interactions, giving the possibility of rendering
stacks of images in 3-dimensional space with the appropriate
blending software. When scanning is performed, 3-dimensional
analyses are important for accurate interpretation of the data and
quantifications. This technological approach allows the adequate
study of intercellular communication at micro-anatomical levels
to understand the intricacy of the glia-mediated inflammatory
response in the brain. Based on these technical specifications and
on the abridged literature, in the following sections, we review
the micro-anatomical details of astrocyte–T-cell interactions in
immune-mediated inflammation.
IMAGING ASTROCYTES AS CHEMOKINE PRODUCERS
AND LYMPHOCYTE ATTRACTANTS
Astrocytes are important players in the formation of the BBB.
Protoplasmic astrocytes, residents of the gray matter, are inti-
mately associated with BVs and, together with pericytes and
endothelial cells, control blood flow and BBB permeability
(Attwell et al., 2010). In the perivascular compartment, astrocytes
are able to produce and release certain proteins that contribute
to the neuro-inflammatory response in the CNS (Croitoru-
Lamoury et al., 2003). Among these proteins, chemokines are
some of the most prominent factors involved in the induc-
tion of the pro-inflammatory environment in tissues (Luster,
1998). Chemokines are small proteins that are released into the
parenchyma or into the blood stream, creating a gradient of
chemo-attractants that other cells follow toward the chemokine
source (Luster, 1998; Murdoch and Finn, 2000). Dendritic cells,
neutrophils, and monocytes, among others, are typical cellu-
lar sources of chemokines in most tissues (Scapini et al., 2000;
Zlotnik and Yoshie, 2000). However, in the brain, astrocytes
appear to assume a significant portion of this role. In vitro,
astrocytes respond to inflammatory stimuli, such as bacterial
lipopolysaccharide (LPS) and pathogens, by expressing CCL and
CXCL chemokines. After LPS treatment to simulate inflammation
in vitro, a strong increase in the release of CCL2 (MCP-1), CCL3
(MIP-1α), CCL5 (RANTES), CXCL1, and CXCL2 is observed
from astrocytes (Van Neerven et al., 2010). Other inflamma-
tory stimuli, such as the treatment of astrocytes with TNF-alpha
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in vitro, also result in the increased expression of several genes
in astrocytes, including those encoding the chemokines CCL2,
CCL5, andCXCL8 (IL-8) (Meeuwsen et al., 2003). Importantly, in
various in vivo models of neurodegenerative diseases, the expres-
sion of these chemokines is increased specifically in astrocytes. In
an experimental model of multiple sclerosis, astrocytes are also
responsible for the release of CCL2, CCL3, and CCL5 (Quinones
et al., 2008). Consistent with this observation, astrocytes were
also found to be the predominant source of CCL2 and CCL3
chemokines in the striatum and the substantia nigra in an experi-
mental model of Parkinson’s disease induced byMPTP (Kalkonde
et al., 2007). In addition, in an experimental model of Alzheimer’s
disease, beta-amyloid was shown to activate astrocytes to produce
CCL2 and CCL5 (Johnstone et al., 1999). Furthermore, in other
scenarios, such as mechanical injury to the brain, chemokines
such as CCL2 are also expressed by astrocytes (Glabinski et al.,
1996).
These findings indicate that, among the chemokines, CCL2
release is a common factor that is important and predomi-
nant in areas of inflammation in the CNS. The mechanism by
which astrocytes are activated and produce CCL2 in brain trauma
or neuro-inflammation is not well-defined, but it is thought
to be associated with stimulation by ATP released at injured
areas, which activates P2X7 receptors in the astrocyte membranes
(Panenka et al., 2001). After injury, CCL2 is expressed by proto-
plasmic reactive astrocytes under pro-inflammatory conditions.
At the cellular level, CCL2 expression, detected by immunore-
activity, is associated with GFAP, although the intracellular co-
localization of both proteins is not complete (Carrillo-de Sauvage
et al., 2012). CCL2 immunoreactivity seems to be particularly
associated with the terminal tips of GFAP filaments (Figure 2),
which suggests a specific role of CCL2 at the edge of astrocyte
filaments. In pro-inflammatory conditions in the brain, such
as following LPS treatment or viral infection, GFAP+CCL2+
astrocytes have the characteristic astrocytic star shape. However,
particularly in brain tumors, GFAP+CCL2+ cells adopt convo-
luted shapes, and CCL2 expression displays different, irregular
patterns (Figure 3), depending on the anatomical complexity of
the tumor. In all three pro-inflammatory scenarios, these CCL2-
rich terminals are specifically related to the neurovascular unit,
FIGURE 2 | Distribution of CCL2 in GFAP+ astrocytes. Confocal rendering
of an area of LPS-induced inflammation in the mouse brain. Astrocytes are
labeled using immunohistochemistry with antibodies against GFAP (green),
and the chemokine CCL2 is stained with anti-CCL2 antibodies (red). Nuclei
are counterstained with DAPI (blue). CCL2 is expressed in astrocytes,
and its intracellular distribution is higher in the terminal GFAP filaments
[modified from Carrillo-de Sauvage et al. (2012)]. Scale bar: 30μm.
suggesting that CCL2 may facilitate the entry of blood cells into
the brain parenchyma (Carrillo-de Sauvage et al., 2012).
Chemokines such as CCL3 and CCL4 mainly function as
macrophage chemo-attractants (Maurer and Von Stebut, 2004),
whereas CCL5 is known to predominantly function in the selec-
tive infiltration of T-cells (Schall et al., 1990; Kawai et al., 1999).
However, it is not clear which mechanisms may drive the differ-
ential entry of particular subsets of cells. For example, CD45RA−
CD45R0+ memory T-cells migrate in response to the combina-
tion of CCL5, CCL2, and CCL3 chemokines (Qin et al., 1996),
which indicates that a particular combination of chemokines may
stimulate the recruitment of specific T-cell subsets. We and oth-
ers have recently shown that CCL2 has a primary role in T-cell
infiltration in inflamed tissues, particularly in tumors (Brown
et al., 2007; Molon et al., 2011; Carrillo-de Sauvage et al., 2012).
However, further research must be performed to clarify the role
of chemokines in the infiltration of specific blood cell types
and to determine whether this response is different in particular
anatomical compartments or in specific inflammatory scenar-
ios. Consistent with this finding, one of the crucial factors that
induces the differential entry of blood cells is the presence of spe-
cific chemokine receptors on the surface of blood cells that signal
the activation of diapedesis and parenchymal entry. In this con-
text, particular chemokines, such as CCL2, are able to induce
the formation of T-cell uropods, which are micro-anatomical
structures that facilitate extravasation (Del Pozo et al., 1997).
Importantly, the recruitment of T-cells into the brain occurs at
the border of BVs where CCL2+ astrocytes are present (Carrillo-
de Sauvage et al., 2012). In the BV border, multiple physical
contacts between T-cells and CCL2+ astrocytes can be observed,
particularly surrounding BVs and in areas of inflammation,
which suggests the involvement of a micro-anatomical interac-
tion with perivascular astrocytes in T-cell diapedesis (Figure 4).
These events are observed in LPS-induced inflammation in mice,
in adenoviral-injected monkeys and in astrocytomas in human
brains (Carrillo-de Sauvage et al., 2012), suggesting that astro-
cytes located at perivascular areasmay play fundamental chemical
and physical roles in recruiting particular T-cell subpopulations
into areas of brain inflammation.
Further studies are required to fully understand the role
of astrocytes in the infiltration of T-cells and the mechanism
underlying the differential entry of specific subpopulations of
lymphocytes into the inflamed brain. Most likely, astrocytes
release different types of chemokines depending on the inflam-
matory milieu, creating a route for specific lymphocyte pop-
ulations to follow. Importantly, disentangling this information
in vivo will have crucial implications for therapeutic strategies for
brain diseases in the near future.
IMAGING THE MUTUAL ARRANGEMENT IN CELL-TO-CELL
IMMUNOLOGICAL ENCOUNTERS
The interaction between astrocytes and lymphocytes in immune-
mediated inflammation is not a static event. Both cell types
undergo different changes in the process of approaching, appos-
ing and contacting each other. As we described in the previous
section, lymphocytes and astrocytes signal to each other to estab-
lish a contact that may result in the entry of lymphocytes into the
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FIGURE 3 | Astrocytes in GBM are able to adopt various shapes and
differentially express chemokines. Three-dimensional reconstruction,
rendered from confocal images, of GFAP/CCL2+ astrocytes within a human
brain tumor section (biopsy from glioblastoma). It is not possible to
distinguish tumorigenic astrocytes from resident astrocytes, but cells adopt
different shapes in the neoplastic areas, ranging from star-shaped cells to
elongated cell bodies with thick and long filaments. The level of co-localization
between GFAP and CCL2 can be observed as a color gradient. This gradient
is shown in the scale on the right. Smaller GFAP+ cells and thinner filaments
are shown in green, with low levels of CCL2 expression (green arrows and
detail in 1). Larger cells and thick filaments are shown in yellow, which
represents high co-localization of both markers (yellow arrows and detail
in 2), suggesting that the expression of CCL2 is highly expressed in reactive
astrocytes. Occasionally, astrocytes also show gem-like buds with large
accumulations of CCL2 (red arrows and detail in 3). These accumulations,
with high CCL2 expression and low GFAP expression, are related to the
infiltration of T-cells into the tumorigenic areas [more information about this
finding is presented in Carrillo-de Sauvage et al. (2012)]. Scale bar: 20μm.
brain parenchyma. However, other types of lymphocyte–astrocyte
contacts that occur in the tissue during immune-mediated anti-
gen presentation may also help us to understand the features of
cell-to-cell arrangements that control brain immune responses.
T-cells form a complex structure called an immunological
synapse (IS) when contacting antigen-presenting cells (APCs)
(Dustin, 2005). At the level of the T-cell–APC interface, this
micro-anatomical structure is characterized by the specific
arrangement of several adhesion molecules and receptors, such
as lymphocyte function-associated antigen (LFA)-1, CD3, and
the T-cell receptor (TCR), as well as the reorganization of
organelles such as the microtubule organizing center (MTOC),
the Golgi apparatus, and the F-actin and alpha-tubulin cytoskele-
ton (Kupfer et al., 1983; Monks et al., 1998; Stinchcombe et al.,
2006). Most of the studies on ISs have focused on the changes
that T-cells undergo, but little attention has been given to APC
transformations. The first visualization of the IS in vivo was
made in T-cells contacting adenovirus-infected astrocytes in the
brain (Barcia et al., 2006). The arrangement of the T-cells in vivo
was similar to the micro-anatomical organization previously
described in vitro (Monks et al., 1998). The arrangement of T-cells
mainly involves the clustering and polarization of the TCR/CD3
complex at the center of the intercellular interface and the seg-
regation of LFA-1 to the outer ring of the interface (Monks
et al., 1998; Dustin, 2005). The role of this arrangement at the
IS remains unclear. The TCR/CD3 complex is particularly impor-
tant in the detection of antigen and in the subsequent signaling
that activates the T-cell. In addition, the LFA-1 arrangement
is crucial in adhesion and cytoskeletal reorganization. LFA-1 is
linked to TALIN and to the cytoskeleton, which guides the polar-
ity of the T-cell after adhesion. These arrangements occur in
T-cells in many immune-mediated scenarios. In the brain, T-cells
rearrange their interface, forming typical mature ISs, when con-
tacting viral-infected astrocytes or glioma cells (Figure 5) (Barcia
et al., 2006, 2009; Yang et al., 2010). It is thought that this complex
arrangement of the T-cell interface is important for a directional
effector response, but further studies are required to unravel its
function. T-cell–APC contact may result in the elimination of
the target cell because of the release of cytotoxic granules, such
as IFN-gamma, granzyme-B, or perforin, by the T-cell at the
synaptic interface. In this context, targeted APCs undergo dif-
ferent morphological and biochemical changes that lead to the
APCs final elimination. T-cell IS formation appears to be funda-
mental for the clearance of astrocytes infected with adenovirus
from the brain (Barcia et al., 2006). In this context, IFN-gamma is
polarized in T-cells at the IS established with adenovirus-infected
astrocytes; thus, IFN-gamma is specifically delivered toward the
synaptic interface for an effective immune response (Barcia et al.,
2008b). In the case of glioma cell clearance, granzyme-B is polar-
ized in cytolytic T-cells and delivered to the synaptic interface
toward the target glioma cell. Granzyme-B induces the specific
cleavage of alpha tubulin (Adrain et al., 2006), disrupting the
glioma cell cytoskeleton (Barcia et al., 2009), and leading to
CTL-mediated apoptosis of the target cells (Goping et al., 2006).
Notably, target astrocytes in intimate immunological contact
with T-cells also have similar molecular and micro-anatomical
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FIGURE 4 | Homing of T-cells in a tumorigenic area in the human brain.
(A) Confocal images of immunofluorescence for CD3+ T-cells (green) and the
chemokine CCL2 (red). Cell nuclei are counterstained with DAPI (blue). CCL2+
astrocytes delimit the outer perivascular area of the BV, whereas T-cells are
localized near CCL2+ perivascular astrocytes. (B) Three dimensional
reconstruction of a detailed region obtained from the confocal images shown
in (A). (C) Three dimensional reconstruction of a blood vessel lumen in a human
glioma. Note that T-cells are apposed to the perivascular CCL2+ cells covering
the internal wall of the BV lumen. Yellow spots represent co-localization of CD3
and CCL2, representing the areas of contact between the two cell types
[Modified from Carrillo-de Sauvage et al. (2012)]. Scale bar: 40μm in (A) and (C);
50μm in (B).
FIGURE 5 | T-cell–GFAP interactions in gliomas. Confocal section
(0.5μm) obtained from a human glioma biopsy. Immunohistochemistry was
performed with anti-GFAP antibodies (red), anti-CD3 antibodies (green) for
T-cells and DAPI for counterstaining (blue). (A) Overview of a blood vessel
(BV) in the tumor area in which two T-cells are contacting GFAP+ cells at
the edge of the vascular lumen. (B) High magnification of the frame
indicated in (A) showing details of the T-cell–GFAP interaction. Importantly,
the apposed T-cell displays clustered CD3 at the interface of the
intercellular contact (arrow) [original findings can be found in Barcia et al.
(2009)]. Scale bar: 15μm.
arrangements as those in lymphocytes. Astrocytes, functioning
as APCs, establish ISs with T-cells and undergo massive mor-
phological changes characterized by a reduction in cell body
size, a reduction in the number of filaments, and the for-
mation of a protrusion toward the area of contact (Figure 6)
(Barcia et al., 2008a). Importantly, the MTOC and the Golgi
apparatus also re-orient toward the interface, frequently contact-
ing the astrocytic protrusion, suggesting that astrocytes actively
respond to T-cell interactions and are not passive APCs. Similar
changes are observed in primary astrocytes in response to a phys-
ical lesion; these astrocytes develop a protrusion and reorient
their MTOC and Golgi apparatus toward the lesion side (Etienne-
Manneville, 2006; Osmani et al., 2006). These results suggest that
T-cell apposition signals to the target astrocyte, inducing changes
that may result in the interchange of crucial information between
the two cells (Figure 7). The function of this symmetric arrange-
ment remains unknown. Astrocytes appear to prepare themselves
to release signaling products toward T-cells. In particular, the ori-
entation of the Golgi apparatus and MTOC is consistent with
these observations. These changes may be related to the transmis-
sion of specific messages such as the confirmation of “kill-me”
signals sent by CTLs or, by contrast, the release of “do-not-kill-
me” signals to avoid elimination. In addition, because astrocytes
have been described to engulf particles or entire cells, it has been
hypothesized that this active rearrangement of astrocytes may also
represent a physical defense of the targeted astrocyte in the pro-
cess of engulfing a T-cell aggressor (Barcia et al., 2008a; Loov et al.,
2012).
T-cell–astrocyte apposition is the result of the mutual
approach of both cells, stimulated by the orchestrated release
of cytokines or chemokines into the extra-cellular environ-
ment. As described above, particular chemokines released by
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FIGURE 6 | Diagrams representing the shape variation that can be found
in T-cell–astrocyte interactions in the rat striatum. Adenovirus-infected
astrocytes display different shapes as the T-cell apposition become closer to
the astrocyte cell body. (A) Typical astrocytic shape in the brain; (B) an
astrocyte in contact with a T-cell lymphocyte (red) at its terminal processes;
(C) an astrocyte in contact with a T-cell lymphocyte (red) distally at the
astrocytic protrusion; (D) an astrocyte in contact with a T-cell lymphocyte
(red) proximally at the astrocytic protrusion; (E) an astrocyte in contact with a
T-cell lymphocyte (red) at the cell body [artistic sketches performed by CB,
modified from Barcia et al. (2008a)].
FIGURE 7 | Diagram of antigen-dependent T-cell–astrocyte
interactions. The interaction of activated T-cells with MHC-expressing
astrocytes involves a defined arrangement of various molecules and
organelles. (A) Schematic representation of the interaction of a T-cell with
an astrocyte at the level of the astrocytic protrusion. (B) Magnification of
the T-cell–astrocyte interface from the frame depicted in (A). The
T-cell–astrocyte interface is characterized by the segregation of adhesion
molecules (such as LFA-1 and ICAM-1), the interaction of the TCR with
MHC molecules, the release of cytotoxic compounds (such as Granzyme-B
or IFN-gamma) into the intercellular space; and the rearrangement and
polarization of organelles toward the interface (for example, the relocation
of the MTOC and Golgi apparatus in both cell types).
astrocytes are responsible for the recruitment of T-cell subsets
into the brain parenchyma. Conversely, cytokines released by
T-cells that have infiltrated into the brain parenchyma inter-
act with local astrocytes and induce specific changes. Particular
subtypes of pro-inflammatory cytokines, such as IFN-gamma,
stimulate the synthesis and consequent expression of MHC
molecules on the astrocytic membrane, and these molecules are
required for the presentation of antigens to T-cells. Indeed, MHC-
expressing astrocytes of the CNS are efficient APCs that are able
to strongly activate antigen-reactive T-lymphocytes (Fierz et al.,
1985; Wekerle et al., 1987). In particular, in the context of the
adaptive immune response in the brain, MHC expression by
astrocytes is highly upregulated by IFN-gamma, which is released
by activated T-cells that infiltrate the brain parenchyma (Richt
et al., 1990; Barcia et al., 2008b). Notably, a detailed micro-
anatomical analysis of MHC expression in astrocytes revealed
that MHC molecules accumulate at a high density in the cell
body and the proximal areas, in contrast to the low levels that
accumulate in the distal areas, such as in filaments or pro-
trusions (Barcia et al., 2008a). These findings suggest that the
astrocytic cell body has a gradient of affinity for T-cells. This strat-
egy of approach and final contact suggests that astrocytes may
have an active and pivotal role in the development of immune
responses in the CNS, acting as APCs in response to cytokines
(Fierz et al., 1985). Thus, T-cell–astrocyte interactions in brain
immune responses may contribute to different outcomes depend-
ing on the released factors. A key element in this modulation
is the fact that specific chemokines or cytokines induce partic-
ular T-cell subpopulation responses and may determine the type
of immune response. Through different mechanisms, astrocytes
are able to both prevent or promote the activation of T-cells
(Wekerle et al., 1987). One of the strategies to suppress T-cell acti-
vation is the upregulation of CTLA-4, which inhibits Th1 and Th2
cell responses occurring with or without astrocyte–T-cell con-
tact (Gimsa et al., 2004). Another strategy is the release of IL-10,
which directly activates regulatory T-cells (Tregs). Both strategies
are able to attenuate cytolytic immune responses in the brain,
which may be beneficial for reducing the aggressive autoim-
mune responses that occur in multiple sclerosis or experimental
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autoimmune encephalomyelitis. By contrast, these approaches
also increase tolerance, which may be advantageous for tumor
cell growth or may facilitate the expansion of infections and
the development of encephalitis. Astrocytes are also able to pro-
mote the activation of T-cells through the release of certain
cytokines by alternative mechanisms. In autoimmune diseases,
astrocytes release IL-15, which contributes to an increase in
T-cell effector function (Saikali et al., 2010), or IL-17, which
activates cytolytic immune responses, facilitating cephalitogenic
responses to local CNS inflammation, such as in multiple
sclerosis.
Thus, the stimulation or inhibition of cytolytic or regu-
latory arms through the release of chemokines or cytokines
by atrocytes may result in markedly different outcomes
that modulate immune responses in the brain. Targeting
cytokines/chemokines or their receptors can alter the course
of several neurological diseases, and the effects may be
beneficial or harmful, depending on the particular situa-
tion (Steinman, 2013). Therefore, the study of the mech-
anisms underlying T-cell–astrocyte communication will be
important for the design of therapeutic strategies for neu-
rodegenerative disorders and brain tumors that show T-cell
infiltration.
CONCLUDING REMARKS
Little is known about intercellular communication in immune-
mediated responses in the brain. Specifically, the role of astrocytes
in adaptive and innate responses has scarcely been explored.
Evidence suggests that protoplasmic astrocytes may have impor-
tant functions in the regulation of immune responses in the
brain, particularly regarding the infiltration of lymphocytes and
their subsequent interactions with APCs once inside the brain
parenchyma.
Many brain disorders, including brain cancer, involve lym-
phocyte infiltration and astrocyte reactivity; nevertheless, the
interactions between these cell types have been largely over-
looked. This large area of research remains to be explored and
will produce extremely valuable information for treating CNS dis-
eases. Astrocyte–lymphocyte communication could be targeted
for therapeutic purposes in the near future.
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